Jazz Pharmaceuticals plc - SHS USD (JAZZ)

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / SHS USD
Total 13F shares
56,398,626
Share change
-79,715
Total reported value
$7,344,865,183
Put/Call ratio
118%
Price per share
$130.21
Number of holders
423
Value change
-$102,973,756
Number of buys
182
Number of sells
260

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2021

As of 30 Sep 2021 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 423 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 56,398,626 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, RENAISSANCE TECHNOLOGIES LLC, Polaris Capital Management, LLC, LSV ASSET MANAGEMENT, and CANADA PENSION PLAN INVESTMENT BOARD.
This table shows 428 institutional shareholders of the security as of 30 Sep 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.